Trademarkia Logo

Canada

C$
stylized semi-circle design
CANCELLED

Last Applicant/ Owned by

Ring Therapeutics, Inc.

140 First Street Cambridge MA 02141

US

Serial Number

2045497 filed on 1st Jul 2020

Registration Number

TMA1124492 registered on 30th Mar 2022

Registration expiry Date

1st Jul 2030

Correspondent Address

SMART & BIGGAR LP

550 Burrard Street, Suite 1900Vancouver

BRITISH COLUMBIA

CA

V6C3A8

stylized semi-circle design

Trademark usage description

encapsulated nucleic acids for use as biological therapeutics in gene therapy for the treatment of rare genetic disorders, cardiovascular diseases, re Read More

Vienna Information


26 . 1 . 1

CirclesCercles

26 . 2 . 1

Segments of circles or ellipses (except 26.2.7)Segments de cercle ou d'ellipse (excepté 26.2.7)

26 . 13 . 25

Other geometrical figures, indefinable designs -- Note: Including scratch marks.Autres figures géométriques, dessins indéfinissables -- Note: Y compris les marques de griffes.

Classification Information


Class [005]
Encapsulated nucleic acids for use as biological therapeutics in gene therapy for the treatment of rare genetic disorders, cardiovascular diseases, respiratory diseases, infectious diseases, retinal diseases, metabolic disorders, hormonal deficiencies, endocrine diseases, eye diseases and disorders, intestinal diseases, autoimmune diseases, auto inflammatory diseases, inflammatory disorders, musculoskeletal diseases, neurological disorders, hematologic conditions, cutaneous conditions, neurodegenerative diseases, congenital disorders, kidney and urinary diseases, reproductive diseases, mitochondrial diseases, lung disorders, immune system diseases, mouth diseases, digestive diseases; pharmaceutical preparations for use in the prevention, diagnosis and treatment of disease, namely, rare genetic disorders, cardiovascular diseases, respiratory diseases, infectious diseases, retinal diseases, metabolic disorders, hormonal deficiencies, endocrine diseases, eye diseases and disorders, intestinal diseases, autoimmune diseases, auto inflammatory diseases, inflammatory disorders, musculoskeletal diseases, neurological disorders, hematologic conditions, cutaneous conditions, neurodegenerative diseases, congenital disorders, kidney and urinary diseases, reproductive diseases, mitochondrial diseases, lung disorders, immune system diseases, mouth diseases, digestive diseases; pharmaceutical preparations for use in gene therapy.


Classification kind code

11

Mark Details


Serial Number

2045497

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 27
on 20th Dec 2021
Approval Notice Sent
Submitted for opposition 26
on 20th Dec 2021
Approved
Submitted for opposition 22
on 14th Dec 2021
Search Recorded
Submitted for opposition 256
on 14th Jun 2021
Notification of Possible Opposition Sent
Submitted for opposition 48
on 2th Feb 2021
Agent Changed
Submitted for opposition 257
on 13th Aug 2020
Designation Notification - Madrid Protocol
Submitted for opposition 31
on 12th Aug 2020
Formalized
Submitted for opposition 1
on 12th Aug 2020
Created
Submitted for opposition 228
on 1st Jul 2020
International Registration
Submitted for opposition 30
on 1st Jul 2020
Filed